Nowadays, a plethora of evidence from electrophysiological and anatomical perspectives has shown that mitochondrial health is essential in the integrity of dopaminergic neurons, especially those in SNc (Bolam and Pissadaki, 2012
These data are the first to examine the application of semaglutide in patients with HS, suggesting semaglutide combined with standard HS therapies can improve patient QOL and lead to fewer HS flares
[1] 5-Amino-1MQ is the short name commonly used for 5-amino-1-methylquinolinium iodide, a quinolinium small molecule studied as an inhibitor of nicotinamide N-methyltransferase (NNMT)
Gao Y, Jiao Y, Gong X, Liu J, Xiao H, Zheng Q
Compounded medications are not reviewed or approved by the U.S
Coordinate with your neurologist before making changes to your treatment plan